From October 2019, the WSM Management Board will be responsible for the overall strategic management of WindStar Medical. As CEO, René Flaschker will take over the chairmanship of the corporate group with its two independently operating divisions Private Label at Dr. Kleine Pharma GmbH and Consumer Brands at Districon GmbH.
CEO and Managing Director of WindStar Medical GmbH
René Flaschker has been CEO and Managing Director of WindStar Medical GmbH since November 2018. With his in-depth knowledge of the industry and his unerring instinct for identifying growth potential, he will lead the WindStar Medical Group.
COO and Managing Director of WindStar Medical GmbH
From 1 October 2019 the internationally experienced manager takes on this newly created position and is responsible for Operations - initially focusing on current transformation projects.
Dr. Andreas Bender
Managing Director of Dr. Kleine Pharma GmbH and CSO
The pharmacist Dr. Andreas Bender has been in a managing position for WindStar Medical since 2008. As of October 1, 2019, he will be responsible for the product range in the private label business and, as Chief Scientific Officer (CSO), will also coordinate scientific and technical topics of the group of companies.
Managing Director Sales of Dr. Kleine Pharma GmbH
Wolfgang Hahn has held a managing position in the WindStar Group since 2009. As a member of the Management Board, he is responsible for sales in the WindStar Medical Private Label business section.
Managing Director Marketing of Districon GmbH
The expert for OTC branding will be responsible for the further development of the brand strategy in the Consumer Brands division from October 2019.
Managing Director Sales of Districon GmbH
Sales expert Sebastian Grosser will take over the distribution of the brand business in the Consumer Brands segment on 1 October 2019.